Get startedLog in
    Picture of Pharming NV logo

    PHARM — Pharming NV Cashflow Statement

    0.000.00%
    nl flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Pharming NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line23.115-12-8.4912.8
    Depreciation
    Non-Cash Items0.062-4.18-6.4811.122.8
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-4.91-1.54-14.7-20.57.86
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities37.822.5-17.3-1.7954.7
    Capital Expenditures-16.7-1.98-1.46-0.796-0.755
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-4.597.3-12832.427
    Acquisition of Business
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-21.35.32-12931.626.3
    Financing Cash Flow Items-29.4-3.95-4.05-5.6-14.1
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-27.9-4.98-1.04-34.41.5
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-13.215.4-146-6.890.4